Idarubicin hydrochloride Injection 20 mg in 20 mL (2)

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

idarubicin hydrochloride, Quantity: 1 mg/mL

Disponible depuis:

Pfizer (Perth) Pty Ltd

forme pharmaceutique:

Injection, solution

Composition:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

Mode d'administration:

Intravenous Infusion

Unités en paquet:

1 x 20 mL

Type d'ordonnance:

(S1) This Schedule is intentionally blank

indications thérapeutiques:

Idamycin PFS Injection in combination with other approved anti leukemic drugs is indicated for the treatment of acute myeloid leukemia (AML) in adults. This includes the French-American-British (FAB) classifications M1 through M7.

Descriptif du produit:

Visual Identification: Plastic vials containing a red-orange, clear, mobile solution.; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Listed (Export Only)

Date de l'autorisation:

2019-05-03